Abstract
Spondyloarthritis represents a heterogeneous group of articular inflammatory diseases that share common genetic, clinical and radiological features. Recently, novel insights into the epidemiology, pathogenesis and treatment of these diseases have been provided. Herewith, we present an overview ofthe most significant literature contributions published over the past year.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antirheumatic Agents / therapeutic use
-
Biological Products / therapeutic use
-
Cytokines / metabolism
-
Humans
-
Incidence
-
Prevalence
-
Spondylarthritis / drug therapy*
-
Spondylarthritis / epidemiology*
-
Spondylarthritis / etiology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antirheumatic Agents
-
Biological Products
-
Cytokines